Price $27.49 |
Market Cap
1.08B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
659.5
|
P/B
4.3
|
P/S
7.93
|
Dividend %
-
|
|
P/CF
59.4
|
P/FCF
-
|
Op. Cash Flow
-5.5K
|
FCF
-
|
|
Op. Margin
4.00%
|
Net Margin
6.20%
|
ROE
5.00%
|
ROI
2.40%
|
|
ROA
4.30%
|
EPS Growth
103.90%
|
Current Ratio
10.5
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Eyenovia Inc (EYEN) | $4.66 | - | - | 127.6M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $10.11 | - | - | 12.5B | Strong Buy |
| RadNet Inc. (RDNT) | $22.11 | - | - | 1.14B | Strong Buy |
| Regulus Therapeutics Inc (RGLS) | $1.23 | - | - | 113.1M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $2.97 | - | - | 45.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
